In contrast, the administration of RSV (100 mg/kg) caused a significant decrease (29.83% and 34.69%, respectively) in serum ALT and AST activities in the NAFLD + RSV group compared to those in the NAFLD group (p = 0.01 and 0.02, respectively; Figure 2). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.